Crowley v. EpiCept Corporation

(United States Ninth Circuit) – Affirming the district court’s judgment for the defense in a diversity action brought by doctors alleging claims arising from their assignment of patents to the company that it failed to develop into FDA-approved drugs because the jury instructions were not improper and the verdict wasn’t against the clear weight of the evidence.